Physician profile
Meredith Moore Walker
NPI 1720040470
$1,221.79
in general payments reported to CMS, 2019-2025
7 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.30 · 2020: $184 · 2021: $60.45 · 2022: $182 · 2023: $404 · 2024: $54.49 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688 · Education: $94.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.93 |
| Education | $94.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $647.16 | 2019-2025 | Nucala, Trelegy Ellipta |
| Insmed, INC. | $290.60 | 2020-2025 | Arikayce |
| Electromed, INC. | $127.04 | 2025 | Smartvest |
| Mylan Specialty L.P. | $63.12 | 2022-2023 | Yupelri |
| Astrazeneca Pharmaceuticals Lp | $59.15 | 2024-2025 | Fasenra, Airsupra |
| United Therapeutics Corporation | $17.63 | 2023 | Tyvaso |
| Vifor Pharma, INC. | $17.09 | 2024 | Veltassa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.